Varex Imaging Corporation designs and manufactures X-ray imaging components. More Details
Moderate growth potential and slightly overvalued.
Share Price & News
How has Varex Imaging's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: VREX's share price has been volatile over the past 3 months.
7 Day Return
US Medical Equipment
1 Year Return
US Medical Equipment
Return vs Industry: VREX underperformed the US Medical Equipment industry which returned 23.8% over the past year.
Return vs Market: VREX underperformed the US Market which returned 17.8% over the past year.
Price Volatility Vs. Market
How volatile is Varex Imaging's share price compared to the market and industry in the last 5 years?
Simply Wall St News
5 months ago | Simply Wall StWhy Varex Imaging Corporation’s (NASDAQ:VREX) Return On Capital Employed Might Be A Concern
10 months ago | Simply Wall StHere's Why Varex Imaging (NASDAQ:VREX) Has A Meaningful Debt Burden
11 months ago | Simply Wall StShould You Be Tempted To Sell Varex Imaging Corporation (NASDAQ:VREX) Because Of Its P/E Ratio?
Is Varex Imaging undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: VREX ($14.33) is trading below our estimate of fair value ($15.39)
Significantly Below Fair Value: VREX is trading below fair value, but not by a significant amount.
Price To Earnings Ratio
PE vs Industry: VREX is unprofitable, so we can't compare its PE Ratio to the US Medical Equipment industry average.
PE vs Market: VREX is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate VREX's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: VREX is good value based on its PB Ratio (1.2x) compared to the US Medical Equipment industry average (4.1x).
How is Varex Imaging forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: VREX is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.2%).
Earnings vs Market: VREX is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: VREX's is expected to become profitable in the next 3 years.
Revenue vs Market: VREX's revenue (0.4% per year) is forecast to grow slower than the US market (10% per year).
High Growth Revenue: VREX's revenue (0.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: VREX's Return on Equity is forecast to be low in 3 years time (4.8%).
How has Varex Imaging performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: VREX is currently unprofitable.
Growing Profit Margin: VREX is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: VREX is unprofitable, and losses have increased over the past 5 years at a rate of 50% per year.
Accelerating Growth: Unable to compare VREX's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: VREX is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (2.5%).
Return on Equity
High ROE: VREX has a negative Return on Equity (-4.78%), as it is currently unprofitable.
How is Varex Imaging's financial position?
Financial Position Analysis
Short Term Liabilities: VREX's short term assets ($498.9M) exceed its short term liabilities ($191.9M).
Long Term Liabilities: VREX's short term assets ($498.9M) exceed its long term liabilities ($448.7M).
Debt to Equity History and Analysis
Debt Level: VREX's debt to equity ratio (87.4%) is considered high.
Reducing Debt: Insufficient data to determine if VREX's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: VREX's debt is not well covered by operating cash flow (11.4%).
Interest Coverage: VREX is unprofitable, therefore interest payments are not well covered by earnings.
What is Varex Imaging current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate VREX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate VREX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if VREX's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if VREX's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of VREX's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Sunny Sanyal (56 yo)
Mr. Sunny S. Sanyal serves as Deputy Chairman at MeVis Medical Solutions AG since 2020. He has been the Chief Executive Officer, President and Director of Varex Imaging Corporation since January 28, 2017. ...
CEO Compensation Analysis
Compensation vs Market: Sunny's total compensation ($USD3.17M) is above average for companies of similar size in the US market ($USD1.93M).
Compensation vs Earnings: Sunny's compensation has increased whilst the company is unprofitable.
|Senior VP||3.75yrs||US$832.79k||0.011% |
|Senior VP & GM of X-Ray Sources||3.75yrs||US$777.66k||0.10% |
|Senior VP & GM of X-Ray Detectors||3.42yrs||US$858.98k||no data|
|Chief Financial Officer||0.25yr||no data||no data|
|Corporate Controller & Chief Accounting Officer||3.75yrs||no data||0% |
|Director of Investor & Public Relations||no data||no data||no data|
|Chief Human Resources Officer & VP||no data||no data||no data|
|Senior VP & GM of Industrial Imaging||2.75yrs||US$781.52k||no data|
|VP & MD for China||2.58yrs||no data||no data|
|Senior Vice President of Medical Global Sales & Marketing||2.75yrs||no data||no data|
|Vice President of Finance||no data||no data||no data|
Experienced Management: VREX's management team is considered experienced (3.4 years average tenure).
|Independent Director||3.75yrs||US$259.48k||0.013% |
|Director||0.083yr||no data||no data|
|Independent Chairman of the Board||3.75yrs||US$347.97k||0.059% |
|Independent Director||3.75yrs||US$253.48k||0.046% |
|Independent Director||2.5yrs||US$244.98k||0.036% |
|Independent Director||3.75yrs||US$253.48k||0.013% |
|Independent Director||3.5yrs||US$239.98k||0.012% |
Experienced Board: VREX's board of directors are considered experienced (3.8 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Varex Imaging Corporation's company bio, employee growth, exchange listings and data sources
- Name: Varex Imaging Corporation
- Ticker: VREX
- Exchange: NasdaqGS
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: US$559.686m
- Shares outstanding: 39.06m
- Website: https://www.vareximaging.com
Number of Employees
- Varex Imaging Corporation
- 1678 South Pioneer Road
- Salt Lake City
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|VREX||NasdaqGS (Nasdaq Global Select)||Yes||Common Shares||US||USD||Jan 2017|
|VI4||DB (Deutsche Boerse AG)||Yes||Common Shares||DE||EUR||Jan 2017|
Varex Imaging Corporation designs and manufactures X-ray imaging components. The company operates in two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-r ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/10/23 00:44|
|End of Day Share Price||2020/10/22 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.